Skip to content
Home
About Us
Science
Investors
News
AGM Material
Menu
Home
About Us
Science
Investors
News
AGM Material
Contact Us
Home
About Us
Science
Investors
News
AGM Material
Menu
Home
About Us
Science
Investors
News
AGM Material
Contact Us
NEWS
Company news and the latest scientific findings
BC
,
VANCOUVER
|
Oct 2023
ME THERAPEUTICS HOLDINGS INC. Announces Listing And Trading Of Its Common Shares On The Canadian Securities Exchange
ME Therapeutics Holdings Inc. (CSE: METX) (the “Company” or “MET”), a preclinical stage biotechnology company working on novel cancer fighting drugs
Read More
BC
,
VANCOUVER
|
Mar 2023
ME THERAPEUTICS INC. Publishes Research On The Role Of G-CSF In Breast And Colorectal Cancer In Cancer Research Communications
ME Therapeutics Inc., a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of Immuno-Oncology, is pleased
Read More
BC
,
VANCOUVER
|
Mar 2023
ME THERAPEUTICS INC. Announces The Grant Of A Chinese Patent On Their Lead G-CSF Antibody Candidate
ME Therapeutics Inc., a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of Immuno-Oncology, is pleased
Read More
<
Page
1
Page
2
>
Check out our profile on SEDAR+
Click here
BC
,
VANCOUVER
|
Jul 2024
ME THERAPEUTICS ANNOUNCES NEW COLLABORATION WITH NANOVATION THERAPEUTICS ON ADVANCED THERAPEUTIC MRNA DELIVERY TO MYELOID CELLS
BC
,
VANCOUVER
|
May 2024
ME THERAPEUTICS HOLDINGS INC. ANNOUNCES THE ADDITION OF TWO NEW CLINICAL CONSULTANTS TO CONTINUE THE ADVANCEMENT OF OUR LEAD ANTI-G-CSF ANTIBODY CANDIDATE TOWARDS A FIRST-IN-HUMAN CLINICAL TRIAL
BC
,
VANCOUVER
|
May 2024
ME THERAPEUTICS TO PRESENT AT INVESTOR CLUBHOUSE AT THE CANADIAN OPEN AND ATTEND THE 2024 BIO INTERNATIONAL CONVENTION FOR PARTNERING OPPORTUNITIES
BC
,
VANCOUVER
|
Apr 2024
ME THERAPEUTICS ANNOUNCES UPCOMING PARTICIPATION IN THE 2024 BLOOM BURTON & CO HEALTH CARE CONFERENCE AND INTERVIEW ON CSE TV
BC
,
VANCOUVER
|
Apr 2024
ME THERAPEUTICS ANNOUNCES CLOSING OF NON-BROKERED PRIVATE PLACEMENT
BC
,
VANCOUVER
|
Mar 2024
ME THERAPEUTICS ANNOUNCES NON-BROKERED PRIVATE PLACEMENT AND PROVIDES CORPORATE UPDATE
BC
,
VANCOUVER
|
Jan 2024
ME THERAPEUTICS HOLDINGS INC. PROVIDES CORPORATE UPDATES
BC
,
VANCOUVER
|
Dec 2023
ME THERAPEUTICS HOLDINGS INC. ANNOUCES LISTING ON THE FRANKFURT STOCK EXCHANGE (FSE) AND THE COMPLETION OF ITS REDESIGNED WEBSITE
BC
,
VANCOUVER
|
Dec 2023
ME THERAPEUTICS HOLDINGS INC. Provides An Overview And Update On Current Research And Development Programs
BC
,
VANCOUVER
|
Oct 2023
ME THERAPEUTICS HOLDINGS INC. Receives Funding Support For Preclinical Testing Of Prodrug Candidates
BC
,
VANCOUVER
|
Oct 2023
ME THERAPEUTICS HOLDINGS INC. Announces Listing And Trading Of Its Common Shares On The Canadian Securities Exchange
BC
,
VANCOUVER
|
Mar 2023
ME THERAPEUTICS INC. Publishes Research On The Role Of G-CSF In Breast And Colorectal Cancer In Cancer Research Communications
BC
,
VANCOUVER
|
Mar 2023
ME THERAPEUTICS INC. Announces The Grant Of A Chinese Patent On Their Lead G-CSF Antibody Candidate
Search
Search
Keep up to date by subscribing to our mailing list
First Name
firstname
Email
JOIN
